This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Cemm Forschungszentrum Fur Molekulare Medizin Gmbh, Mobius Biotechnology Gmbh. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 
1 out of 1 Years Active: 2016-2026
Title: Giulio Superti-Furga: A Contributor to Molecular Medicine
Introduction
Giulio Superti-Furga is an influential figure in the field of molecular medicine based in Austria. Although he currently holds no patents, his work at CEMM Forschungszentrum für Molekulare Medizin GmbH contributes significantly to the advancement of medical science and insights into molecular biological mechanisms.
Latest Patents
As of now, Giulio Superti-Furga does not hold any patents. His focus is primarily on research and development within his institution, working alongside his colleagues to push the boundaries of knowledge in molecular medicine.
Career Highlights
At CEMM Forschungszentrum für Molekulare Medizin GmbH, Giulio Superti-Furga has made numerous contributions to research that can lead to medical innovations. His expertise and leadership in various projects highlight his commitment to enhancing our understanding of molecular pathways related to health and disease.
Collaborations
During his career, Superti-Furga has collaborated with notable colleagues such as Berend Snijder and Gregory Ian Vladimer. These partnerships serve to enrich the research environment and foster innovative ideas that can transform the field of molecular medicine.
Conclusion
Giulio Superti-Furga's contributions to molecular medicine, despite the absence of patents, reflect a dedication to scientific research and collaboration. His role at CEMM Forschungszentrum für Molekulare Medizin GmbH positions him well within the community, making strides towards impactful medical discoveries and innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile